Redeye 2022-11-11: Diskussion kring bolagets kvartalsrapport, partneringprocessen och PK-studien.
In Short
Respiratorius AB (publ) develops candidate drugs with the goal of launching drugs to treat aggressive lymphoma (cancer).
CONTACT
Respiratorius AB
Medicon Village
Scheeletorget 1, 223 81 Lund, Sweden
info@respiratorius.com
+46 70 922 41 40